Download full announcement Surge in Chronic Kidney Disease and Kidney Failure Expected Post-COVID-19Mount Sinai-Led Study to Assess 4,000 Surviving COVID-19 Patients NEW YORK, August 3, 2020 – Mount Sinai Health System... read more →
Download full announcement For the purposes of DTR5.6.1R of the Transparency Directive, the Company notifies the market of the following: As of 31 July 2020, the Company's issued and fully paid... read more →
Download full announcement Renalytix AI plc (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare... read more →
Download full announcement Renalytix AI plc (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare... read more →
Download full announcement Renalytix AI plc (LSE: RENX), a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower... read more →
Download full announcement Renalytix AI plc (LSE: RENX), a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower... read more →
Download full announcement Renalytix AI plc (LSE: RENX), a commercial-stage artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower... read more →
Download full announcement Renalytix AI plc (LSE: RENX), the AIM-traded developer of clinical grade artificial intelligence in vitro diagnostics for kidney disease, announces that the KidneyIntelX™ platform will be used by investigators from the... read more →
Download full announcement Agreement with Three Rivers Provider Network, the fastest growing US proprietary provider network KidneyIntelX risk assessment testing now available to Three Rivers members and clients Renalytix AI plc... read more →
Download full announcement Lombard Odier Asset Management Place of completion London, United-Kingdom Date of completion 27/03/2020